RNA5SP101

Across TCGA pan-cancer cohorts, RNA5SP101 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RNA5SP101’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where RNA5SP101 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNA5SP101 is over-expressed in tumor, although a few such as BRCA and BLCA show the opposite, repressed pattern.

BRCA, BRCA, and BLCA are the cancer types where RNA5SP101 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNA5SP101 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	II,III,IV	+0.306	.015	4	view →
BRCA	All	IV	−1.310	<.001	2	view →
BLCA	All	IV	−0.488	.032	2	view →
UCEC	All	All	−0.487	.010	2	view →
HNSC	Male	II,III,IV	+0.123	.034	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 4 lineages.

RNA5SP101–BRCA

Open the BRCA breakdown →